| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 34, 2456-2459, Copyright © 1988 by American Association for Clinical Chemistry
JS Cohn, JR McNamara and EJ Schaefer
USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111.
Lipoprotein cholesterol concentrations in plasma are routinely estimated by using the Friedewald formula, whereby very-low-density lipoprotein cholesterol (VLDL-C) is estimated to be one-fifth the plasma triglyceride concentration. Ordinarily, this formula is applied only to plasma sampled from patients in the fasted state. To determine whether lipoprotein cholesterol measurements are altered substantially in plasma sampled from nonfasting subjects, we obtained postprandial blood samples from 22 healthy subjects (nine men, 13 women, ages 22-79 years) fed a fat-rich meal (1 g fat per kilogram body wt.). The plasma triglyceride concentration increased postprandially in all subjects (233 +/- 16% of baseline at 3 h). The mean cholesterol concentration in plasma was essentially unchanged. High-density lipoprotein cholesterol (HDL-C) was significantly decreased (94 +/- 2% at 3 h, P less than 0.001). VLDL-C and low-density lipoprotein cholesterol (LDL-C), estimated by the Friedewald formula, were compared with measurements obtained by modified Lipid Research Clinics (LRC) methodology. As measured by either method, VLDL-C increased and LDL-C decreased significantly after the fat-rich meal. These postprandial changes were significantly greater (P less than 0.01) when estimated by the Friedewald formula than by LRC methodology. We conclude that (a) lipoprotein cholesterol concentrations measured in the fed subject differ significantly from those measured in the fasted subject, and (b) plasma must be obtained after at least a 12-h fast if an individual's risk of coronary heart disease is to be accurately assessed.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  V. Leoni, C. Mariotti, S. J. Tabrizi, M. Valenza, E. J. Wild, S. M. D. Henley, N. Z. Hobbs, M. L. Mandelli, M. Grisoli, I. Bjorkhem, et al. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease Brain, November 1, 2008; 131(11): 2851 - 2859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mora, N. Rifai, J. E. Buring, and P. M Ridker Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events Circulation, September 2, 2008; 118(10): 993 - 1001. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kelley-Hedgepeth, D. M. Lloyd-Jones, A. Colvin, K. A. Matthews, J. Johnston, M. R. Sowers, B. Sternfeld, R. C. Pasternak, C. U. Chae, and for the SWAN Investigators Ethnic Differences in C-Reactive Protein Concentrations Clin. Chem., June 1, 2008; 54(6): 1027 - 1037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S Lund, L. Tarnow, M. Frandsen, U. M Smidt, O. Pedersen, H.-H. Parving, and A. A Vaag Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes Eur. J. Endocrinol., January 1, 2008; 158(1): 35 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Soyama, K. Miura, Y. Morikawa, M. Nishijo, Y. Nakanishi, Y. Naruse, S. Kagamimori, and H. Nakagawa High-Density Lipoprotein Cholesterol and Risk of Stroke in Japanese Men and Women: The Oyabe Study Stroke, April 1, 2003; 34(4): 863 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Sonawalla, G. I. Papakostas, T. J. Petersen, A. S. Yeung, M. M. Smith, A. H. Sickinger, J. Gordon, J. A. Israel, J. R. Tedlow, S. Lamon-Fava, et al. Elevated Cholesterol Levels Associated With Nonresponse to Fluoxetine Treatment in Major Depressive Disorder Psychosomatics, August 1, 2002; 43(4): 310 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-Z. Liu, R. A. Shaw, A. Man, T. C. Dembinski, and H. H. Mantsch Reagent-free, Simultaneous Determination of Serum Cholesterol in HDL and LDL by Infrared Spectroscopy Clin. Chem., March 1, 2002; 48(3): 499 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nauck, G. R. Warnick, and N. Rifai Methods for Measurement of LDL-Cholesterol: A Critical Assessment of Direct Measurement by Homogeneous Assays versus Calculation Clin. Chem., February 1, 2002; 48(2): 236 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. GARLAND, D. HICKEY, A. CORVIN, J. GOLDEN, P. FITZPATRICK, S. CUNNINGHAM, and N. WALSH Total serum cholesterol in relation to psychological correlates in parasuicide The British Journal of Psychiatry, July 1, 2000; 177(1): 77 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Ticho, E. J. Neufeld, J. W. Newburger, N. Harris, A. Baker, and N. Rifai Utility of Direct Measurement of Low-Density Lipoprotein Cholesterol in Dyslipidemic Pediatric Patients Arch Pediatr Adolesc Med, August 1, 1998; 152(8): 787 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Rifai, E. Iannotti, K. DeAngelis, and T. Law Analytical and clinical performance of a homogeneous enzymatic LDL-cholesterol assay compared with the ultracentrifugation-dextran sulfate-Mg2+ method Clin. Chem., June 1, 1998; 44(6): 1242 - 1250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Harris, V. Galpchian, J. Thomas, E. Iannotti, T. Law, and N. Rifai Three generations of high-density lipoprotein cholesterol assays compared with ultracentrifugation/dextran sulfate–Mg2+ method Clin. Chem., May 1, 1997; 43(5): 816 - 823. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
